| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 03/02/2011 | EP2289564A2 Derivatives of aniline as precursors for F18-labeling |
| 03/02/2011 | EP2289563A1 Near infrared fluorescent imaging agent |
| 03/02/2011 | EP2289562A1 Near infrared fluorescent imaging agent |
| 03/02/2011 | EP2289559A1 Anit-CD70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders |
| 03/02/2011 | EP2289553A1 Dispersant stabilization of inorganic non-metallic particles |
| 03/02/2011 | EP2289490A1 Charged lipoprotein complexes and their uses |
| 03/02/2011 | EP1639004B1 Fluorescein-labelled peptides |
| 03/02/2011 | EP0800545B2 Targeted magnetically labeled molecular marker systems for the nmr imaging |
| 03/01/2011 | US7897336 Using a dye or radioactive tracer in conjunction with nucleic acid marker; cancer diagnosis and prognosis; drug delivery, gene therapy, activation of tumor immunity and inhibiting metastasis |
| 03/01/2011 | US7897141 Ultrasound contrast agents; dissolving subliming, water insoluble substance then polymer in nonpolar solvent; emulsifying, adding surfactant and hardening; reproducible size |
| 03/01/2011 | US7896816 Skin test device |
| 03/01/2011 | CA2348488C Novel agents and methods for treatment and diagnosis of ocular disorders |
| 02/24/2011 | WO2011022706A2 Methods and compositions for treatment of pulmonary fibrotic disorders |
| 02/24/2011 | WO2011022670A1 In vivo screening assays |
| 02/24/2011 | WO2011021001A1 Peptidic conjugates comprising polyhistidine sequence and free cysteine and their uses in imaging |
| 02/24/2011 | WO2010121133A3 Multimodal imaging of fibrin |
| 02/24/2011 | US20110045031 Use of Buckysome or Carbon Nanotube for Drug Delivery |
| 02/24/2011 | US20110044912 Diagnostic And Therapeutic Epitope, And Transgenic Plant |
| 02/24/2011 | US20110044911 Use of Functionalized Magnetic Nanoparticles in Cancer Detection and Treatment |
| 02/24/2011 | US20110044910 In vivo flow cytometry based on cellular autofluorescence |
| 02/24/2011 | US20110044909 Animal model for diabetes |
| 02/24/2011 | US20110044908 Methods and Compositions for Treating and Identifying Compounds to Treat Age-Related Macular Degeneration |
| 02/24/2011 | US20110044907 In vivo screening assays |
| 02/24/2011 | US20110044906 Methods for the Treatment, the Prognostic Assessment and the Staging of Non-Small Cell Lung Cancer |
| 02/24/2011 | US20110044905 Oxytocin analogues |
| 02/24/2011 | US20110044904 Crystal forms of 2--adenosine |
| 02/24/2011 | US20110044903 Methods for producing microbubbles |
| 02/24/2011 | US20110044902 Modulation of the Immune Response |
| 02/24/2011 | US20110044901 Novel compounds |
| 02/24/2011 | US20110044900 Method for treating and/or diagnosing tumor by gold particles coated with a polymer |
| 02/24/2011 | US20110044898 Translocator protein ligands |
| 02/24/2011 | US20110044897 Method of imaging localized infections |
| 02/24/2011 | US20110044896 Tumor-targeting monoclonal antibodies to FZD10 and uses thereof |
| 02/24/2011 | US20110044895 Methods and compositions for reducing stemness in oncogenesis |
| 02/24/2011 | US20110044893 Vascular targets for detecting, imaging and treating neoplasia or neovasculature |
| 02/23/2011 | EP2287613A2 Detection, monitoring and treatment of cancer |
| 02/23/2011 | EP2286843A2 Compounds for targeting endothelial cells |
| 02/23/2011 | EP2286799A2 Microspheres for active embolization |
| 02/23/2011 | EP2286798A1 Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| 02/23/2011 | EP2286795A1 Method of producing a cationic liposomal preparation comprising a lipophilic compound |
| 02/23/2011 | EP2285423A1 Biocompatible polymer and magnetic nanoparticle with biocompatibility |
| 02/23/2011 | EP2285422A2 Dual-modality pet/mri contrast agents |
| 02/23/2011 | EP2285421A2 Methods for production and use of substance-loaded erythrocytes (s-les) for observation and treatment of microvascular hemodynamics |
| 02/23/2011 | EP2285420A2 Polyelectrolyte with positive net charge for use as medicament and diagnostic for cancer |
| 02/23/2011 | EP2285417A1 Imaging methods and compositions comprising fluorescent dyes associated with viral components for nerve imaging |
| 02/23/2011 | CN101979605A Reporter gene labeled-mouse model for monitoring function of HBV specific CTLs in vivo and construction method and application thereof |
| 02/23/2011 | CN101979398A Thymine compound and application thereof as molecular probe target material |
| 02/23/2011 | CN101979097A Gadolinium-containing magnetic resonance contrast agent and preparation method thereof |
| 02/23/2011 | CN101979096A Gold and iodine element-supported arborescent macromolecular computed tomography (CT) targeted contrast medium and preparation thereof |
| 02/23/2011 | CN101979095A Treatment and diagnosis of macrophage mediated disease |
| 02/22/2011 | US7893223 Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 02/22/2011 | US7893207 Fluorescent and colored proteins, and polynucleotides that encode these proteins |
| 02/22/2011 | US7892547 Methods and compositions for administering therapeutic and diagnostic agents |
| 02/22/2011 | US7892522 Administering contrast-enhancing amount of a contrast agent comprising microbubbles of biocompatible gas stabilised by opsonisable amphiphilic material, allowing liver to take up; generating ultrasound image of liver |
| 02/17/2011 | WO2011020107A2 Compositions and methods for detection and treatment of breast cancer |
| 02/17/2011 | WO2011019074A1 Nucleic acid that controls fibrosis of cells or organs |
| 02/17/2011 | WO2011018624A1 Ultrasound couplant |
| 02/17/2011 | WO2010141704A3 Imaging of myelin basic protein |
| 02/17/2011 | US20110041190 Novel chimeric proteins |
| 02/17/2011 | US20110038926 Method of producing a cationic liposomal preparation comprising a lipophilic compound |
| 02/17/2011 | US20110038804 Mr imaging agent, imaging medium and methods of imaging wherein such an imaging medium is used |
| 02/17/2011 | US20110038803 specifically and efficiently traps nitrogen monoxide, zinc ion etc. to emit fluorescence; used to measure nitrogen monoxide or metal ions in a deep tissue of a living body |
| 02/17/2011 | US20110038802 Method of determining alanine transaminase (alt) activity by 13c-mr detection using hyperpolarised 13c-pyruvate |
| 02/17/2011 | US20110038801 Methods and compositions for identifying lung cancer or a humoral immune response against lung cancer |
| 02/17/2011 | US20110038800 Method for the treatment or prophylaxis of lymphagioleiomymatosis (lam) and animal model for use in lam research |
| 02/17/2011 | US20110038799 Composition for treatment and improvement of diabetes comprising caveolin as active ingredient and a method for treatment of diabetes using it |
| 02/17/2011 | US20110038798 Agents for detecting and imaging cell death |
| 02/17/2011 | US20110038797 Method for detecting inflammatory disorders of the central nervous system |
| 02/17/2011 | US20110038793 Microsphere comprising an organic lanthanide metal complex |
| 02/17/2011 | US20110038790 Treatment and prophylaxis of amyloidosis |
| 02/17/2011 | CA2770837A1 Ultrasound couplant |
| 02/16/2011 | EP2284180A2 Peptides that specifically bind HGF receptor (CMET) and uses thereof |
| 02/16/2011 | EP2283872A2 Non-covalent bioconjugates useful for diagnosis and therapy |
| 02/16/2011 | EP2283871A1 Imaging infection with compounds that bind to thymidine kinase |
| 02/16/2011 | EP2283869A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in the treatment of viral infections and cancer |
| 02/16/2011 | EP2282782A1 Methods for radiolabelling macromolecules |
| 02/16/2011 | EP2282781A1 Methods for radiolabelling synthetic polymers |
| 02/16/2011 | EP2282780A2 In vivo mr imaging with contrast agents comprising a metal-binding protein, polypeptide or peptide |
| 02/16/2011 | EP2282775A2 Vector for use in medicine |
| 02/16/2011 | EP2282712A2 Medical microbubble generation |
| 02/16/2011 | CN101977634A Method for the synthesis of hollow spheres |
| 02/16/2011 | CN101977633A Process for preparing a pharmaceutical formulation of contrast agents |
| 02/16/2011 | CN101974480A Liver engrafting cells, assays, and uses thereof |
| 02/16/2011 | CN101972485A Chinese traditional medicine capsule for intestinal ultrasonic imaging |
| 02/16/2011 | CN101972484A Novel method of early cancer diagnosis based on gold nanorod |
| 02/15/2011 | US7888330 Phosphoramidate derivatives of FAU |
| 02/15/2011 | US7888114 encoding a Herpesviridae thymidine kinase enzyme comprising one or more mutations; for gene therapy, cancer |
| 02/15/2011 | US7888091 Fusion proteins having thymidine kinase and guanylate kinase activities |
| 02/15/2011 | US7888039 uses the heat shock protein 60 (Hsp60) of Spiroplasma mirum; rapid detection, noninvasive ; Spiroplasma infection |
| 02/15/2011 | US7888001 Applying filtered UVA light to the nevus forming light induced melanin radicals; measuring levels of stable melanin radicals and intensity light-induced melanin radicals; Electron Paramagnetic Resonance, in vivo, ex vivo; establish a Melanocyte Protection Factor in heavily pigmented target cell |
| 02/15/2011 | US7887833 Amphiphilic compounds and vesicles liposomes for organ-specified drug targeting |
| 02/15/2011 | CA2482305C Cavity filling biopsy site markers |
| 02/15/2011 | CA2459724C Multi-use multimodal imaging chelates |
| 02/15/2011 | CA2452445C Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof |
| 02/15/2011 | CA2192235C Flt4 receptor tyrosine kinase and its use in diagnosis and therapy |
| 02/10/2011 | WO2011017690A2 Intracellular delivery of contrast agents with functionalized nanoparticles |
| 02/10/2011 | WO2011016605A1 Dtpa derivative, metal complex, mr and ct contrast agent and method for manufacturing same |
| 02/10/2011 | WO2011016487A1 Indigocarmine preparation |
| 02/10/2011 | WO2011015670A2 Metal oxide particles coated with polyethylene glycol and their synthesis |
| 02/10/2011 | US20110034753 Stem cell targeting and activation using magnetic particles |